First of all, there is no such thing as hemophilia C. Second,
Type A:
A mutation in the
factor VIII gene.
Type B:
A mutation in the IX
gene.
Both of these genes are need to help clot the blood and close wounds(scabbing).
It is named after the first patient who was described with the symptoms of Hemophilia type B, Stephen Christmas.
hemophilia B is also known as Christmas disease because Stephen Christmas was the first patient with the disease, and hemophilia A is just known as classic hemophilia.
Many years ago, it was refered to as 'the Royal Disease" also the "Bleeding disease". Hemophilia B is also known as Christmas Disease.
Royal Hemophilia is a reference to Hemophilia B, also known as Factor IX (9) deficiency. This is a genetic disorder that can be inherited. Also near 30% of the Hemophilia B cases result from spontaneous mutations and are not inherited at all. That being said, once the mutation has occurred, that individual can pass the mutation on.
There are two types of hemophilia. Type A: A mutation in the factor VIII gene. Type B: A mutation in the IX gene.
Hemophilia is broken into three subcategories; Hemophilia A, Hemophilia B, and Hemophilia C. These subcategories designate a person as having a deficiency of one of three specific clotting proteins. Hemophilia A is the deficiency of the protein called Clotting Factor VIII. Hemophilia B is the deficiency of Clotting Factor IX. Hemophilia C is the deficiency of Clotting Factor XI. "Royal" hemophilia is simply a reference to Hemophilia B and is therefore a result of a deficiency in the Clotting Factor IX protein. It is sometimes called the royal disease because it has been known to have been passed through some royal families throughout history.
There are two types of hemophilia: hemophilia A (sometimes called classical hemophilia) and hemophilia B (sometimes called Christmas disease). Both are caused by a low level or absence of one of the proteins in the blood (called factors) that control bleeding. Hemophilia A is caused by a deficiency of factor VIII, and hemophilia B is caused by a deficiency of factor IX. There is no difference between the two types of hemophilia, except that hemophilia B is about five times less common than hemophilia A.
Other than a liver transplant the is hardly an ideal solution, there is no cure for Hemophilia A or B as of yet.
She is rumored to have Hemophilia type B. no one is sure if it is true.
It is named after the first patient who was described with the symptoms of Hemophilia type B, Stephen Christmas.
There are three types of hemophilia: A, B, CQueen Victoria was a carrier of hemophilia B.Proteins are blood-clotting factors that hemophiliacs lack.Hemophilia A is Clotting Factor VIII deficiency.Hemophilia B is Clotting Factor IX deficiency.Hemophilia C is Clotting Factor XI deficiency.Hemophiliacs do not bleed more than other people, they simply bleed longer.Hemophilia is NOT contagious.
hemophilia B is also known as Christmas disease because Stephen Christmas was the first patient with the disease, and hemophilia A is just known as classic hemophilia.
it will become more superstitious or it will become powerful.
Healthy Body Healthy Mind - 2003 Understanding Hemophilia and Hemophilia B 26-3 was released on: USA: 11 April 2013
No. There are several types of bleeding disorders. Hemophilia is a deficiency in clotting factor proteins VIII (Hemophilia A), IX (Hemophilia B), or XI (Hemophilia C). There are several other clotting factor proteins linked to coagulation, as well as the vonWillebrands protein, and platelet disorders. Hemophilia is simply the most widely recognized (by the general public) bleeding disorder. It is important to know that many other bleeding disorders exist, such as the platelet deficiency you are asking about.
Hemophilia A is an X-linked, hereditary bleeding disorder caused by the absence or defect of a blood clotting protein, Factor VIII. As a result, when a person with hemophilia A has a bleeding episode, the bleeding may be prolonged due to the body's inability to form blood clots. Patients who are affected with hemophilia A experience frequent spontaneous bleeding, most commonly into their joints and soft tissues, with bleeding into vital organs that may ... be life-threatening. Bleeding episodes may be painful, and over time, recurrent joint bleeding may result in debilitating destruction of the joints. Currently, patients with hemophilia A are dependent on injections of Factor VIII produced by genetic engineering or purified from human plasma, to help control a bleeding episode. It is estimated that approximately 50,000 individuals worldwide are affected with hemophilia A. Hemophilia A - Clotting Factor VIII Hemophilia B - Clotting Factor IX Hemophilia C - Clotting Factor XI
Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.Hemophilia A affects between one in 5,000 to one in 10,000 males in most populations. Hemophilia B occurs in one in 40,000 to 50,000. The prevalence of hemophilia is estimated to be 13.4 cases per 100,000 U.S. males (10.5 hemophilia A and 2.9 hemophilia B). By race/ethnicity, the prevalence is 13.2 cases in 100,000 among white males, 11.0 among African-American males, and 11.5 among Hispanic males. Hemophilia C occurs primarily among individuals of Jewish descent.For the source and more detailed information concerning this request, click on the related links section (Answers.com) indicated below this answer box.